600664:SHA
Harbin Pharmaceutical Group Co Ltd
CN¥ 6.19
arrow_upward
+0.49%(+0.030) 1D
10-р сарын 15, 15:00:00 (GMT+8) · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 600664...
Open
CN¥ 6.05
High
CN¥ 6.50
Low
CN¥ 5.99
Mkt. cap
16.52 тэрбум
Avg. vol.
382.73 сая
Volume
377.39 сая
P/E ratio
30.44
52-wk high
CN¥ 9.86
52-wk low
CN¥ 2.84
EPS
CN¥ 0.20
Shares outstanding
2.54 тэрбум
No. of employees
10 мян
Open
CN¥ 6.05
High
CN¥ 6.50
Low
CN¥ 5.99
Mkt. cap
16.52 тэрбум
Avg. vol.
382.73 сая
Volume
377.39 сая
P/E ratio
30.44
52-wk high
CN¥ 9.86
52-wk low
CN¥ 2.84
EPS
CN¥ 0.20
Shares outstanding
2.54 тэрбум
No. of employees
10 мян
News stories
From web sources and news partners
GlobeNewswire
·
38 минутын өмнө
AZIO AI Holdings Inc. (NASDAQ: AZIO) Building Solution to
Timothy Sykes
·
36 минутын өмнө
VBIO Regains Nasdaq Compliance And Files $100M Shelf
CNN
·
2 цагийн өмнө
Global tech selloff deepens as enthusiasm for AI stocks wobbles
Seeking Alpha
·
46 минутын өмнө
The Outlook For S&P 500 Dividends In October 2026 (undefined:SPX)
Profile
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
About Harbin Pharmaceutical Group Co Ltd